Session

Back to Programme Overview

Joint Session of the European Association of Urology (EAU) and the Japanese Urological Association (JUA)

Urology beyond Europe

  • Location:
    Room 7, Capital suite (level 3)
  • Chairs:
     C.R. Chapple, Sheffield (GB)
     S. Egawa, Tokyo (JP)
  • Aims and objectives of this session

    To discuss debatable issues in urological practice through case discussions

Welcome and introduction
 
 C.R. Chapple, Sheffield (GB)
 
 S. Egawa, Tokyo (JP)
Prostate Cancer
 
Moderators:
 S. Horie, Tokyo (JP)
 
 
 D.J. Rosario, Sheffield (GB)
Extending the use of androgen receptor targeted drugs in men with nmCRPC
Yes
 T. Kimura, Tokyo (JP)
No
 A. Briganti, Milan (IT)
Panel discussion on clinical cases: What is your choice of treatment?
Panel:
 D.J. Rosario, Sheffield (GB)
 
 S. Maruyama, Sapporo (JP)
 
 Y. Matsui, Kyoto (JP)
 
 H.G. Van Der Poel, Amsterdam (NL)
Renal cell carcinoma
 
Moderators:
 M.J. Ribal, Barcelona (ES)
 
 
 Y. Tomita, Niigata (JP)
Second line treatment for metastatic or unresectable RCC with nivolumab
Yes
 B. Mellado, Barcelona (ES)
No
 M. Takahashi, Tokushima (JP)
Panel discussion on clinical cases: How to approach this situation?
Panel:
 B. Mellado, Barcelona (ES)
 
 A.S. Merseburger, Lübeck (DE)
 
 M.J. Ribal, Barcelona (ES)
 
 R. Takata, Morioka (JP)
 
 R. Tanimoto, Okayama (JP)
 
 Y. Tomita, Niigata (JP)
Underactive bladder/Detrusor underactivity
 
Moderators:
 C.R. Chapple, Sheffield (GB)
 
 
 N. Sekido, Tokyo (JP)
Animal model of underactive bladder/ detrusor underactivity
 N. Sekido, Tokyo (JP)
Current definition and emerging therapy of underactive bladder/detrusor underactivity
 C.R. Chapple, Sheffield (GB)
Panel discussion on clinical cases: How do you treat this patient? Differences in approach to underactive bladder
Panel:
 Y. Matsukawa, Nagoya (JP)
 
 T. Mitsui, Sapporo (JP)
 
 M. Oelke, Hanover (DE)
 
 G. Van Koeveringe, Maastricht (NL)
Conclusion
 
 M. Fujisawa, Kobe (JP)
 
 S. Egawa, Tokyo (JP)